Literature DB >> 7315445

Cardiac effects of splanchnic and non-splanchnic blood volume redistribution during aortic occlusions in dogs.

O Stokland, M Molaug, J Thorvaldson, A Ilebekk, F Kiil.   

Abstract

Translocation of blood from the lower body dilates the left ventricle during occlusion of the descending thoracic aorta and by increased activation of the Frank-Starling mechanism, stroke volume is maintained despite raised aortic blood pressure. The contributions from the splanchnic and non-splanchnic blood volumes to the left ventricular dilation were examined by ultrasonic measurements of myocardial chord length (MCL) in atropinized open-chest dogs. End-diastolic MCL rose by 2.5 +/- 0.9% during abdominal suprarenal aortic occlusion, draining blood from the non-splanchnic region, and by 7.4 +/- 1.7% during thoracic aortic occlusion draining blood from both splanchnic and non-splanchnic regions. Systolic left ventricular pressure rose by 16 +/- 3 mmHg and 76 +/- 12 mmHg, respectively. End-diastolic MCL rose by 6.0 +/- 1.2% during combined thoracic aortic and abdominal infrahepatic vena cava occlusion draining blood solely from the splanchnic region and further by 2.5 +/- 0.8% by blood drained from the non-splanchnic region after release of the vena cava occlusion. Similar results were obtained using a shunt permitting selective drainage first from the non-splanchnic region during thoracic aortic occlusion. Blood translocation from the non-splanchnic region maintains cardiac output during abdominal aortic occlusion. During occlusion of the thoracic aorta, drainage from the splanchnic region accounts for about 70% of the increase in end-diastolic MCL.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7315445     DOI: 10.1111/j.1748-1716.1981.tb06874.x

Source DB:  PubMed          Journal:  Acta Physiol Scand        ISSN: 0001-6772


  1 in total

Review 1.  Aortic occlusion for cerebral ischemia: from theory to practice.

Authors:  David S Liebeskind
Journal:  Curr Cardiol Rep       Date:  2008-02       Impact factor: 2.931

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.